Zobrazeno 1 - 10
of 1 005
pro vyhledávání: '"Margaritis, T."'
Autor:
Kluiver TA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Lu Y; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Department of Hepatobiliary Surgery, Xiamen Hospital of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Xiamen, China., Schubert SA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Kraaier LJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Ringnalda F; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Lijnzaad P; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., DeMartino J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Megchelenbrink WL; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Department of Precision Medicine, University of Campania Luigi Vanvitelli, Vico L. De Crecchio 7, Naples, Italy., Amo-Addae V; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Eising S; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., de Faria FW; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Albert-Schweitzer-Campus 1, Münster, Germany., Münter D; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Albert-Schweitzer-Campus 1, Münster, Germany., van de Wetering M; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Kerl K; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Albert-Schweitzer-Campus 1, Münster, Germany., Duiker E; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., van den Heuvel MC; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., de Meijer VE; Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., de Kleine RH; Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Margaritis T; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Stunnenberg HG; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, the Netherlands., Zsiros J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands., Clevers H; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center, Utrecht, the Netherlands.; Pharma, Research and Early Development (pRED) of F. Hoffmann-La Roche Ltd, Basel, Switzerland., Peng WC; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, the Netherlands. w.c.peng@prinsesmaximacentrum.nl.
Publikováno v:
Nature communications [Nat Commun] 2024 Nov 20; Vol. 15 (1), pp. 8576. Date of Electronic Publication: 2024 Nov 20.
Autor:
Koedijk JB; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus MC/Sophia Children's Hospital, 3015 GD, Rotterdam, The Netherlands., van der Werf I; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, 3521 AL, Utrecht, The Netherlands.; Sanford Stem Cell Institute, Division of Regenerative Medicine, Department of Medicine, University of California San Diego, La Jolla, CA, USA., Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Hematology, Oncology, and Cancer Immunology, Campus Virchow Klinikum, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program, Charitéplatz 1, 10117, Berlin, Germany., Vermeulen MA; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands., Barneh F; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands., Perzolli A; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus MC/Sophia Children's Hospital, 3015 GD, Rotterdam, The Netherlands., Meesters-Ensing JI; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands., Metselaar DS; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium (DKTK), Im Neuenheimer Feld 280, Heidelberg, Germany., Margaritis T; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands., Fiocco M; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands.; Mathematical Institute, Leiden University, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., de Groot-Kruseman HA; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands., Moeniralam R; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands., Bang Christensen K; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark., Porter B; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Pfaff K; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Hasle H; Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark., Nierkens S; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands., Belderbos ME; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands., Zwaan CM; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus MC/Sophia Children's Hospital, 3015 GD, Rotterdam, The Netherlands., Heidenreich O; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands. o.t.heidenreich@prinsesmaximacentrum.nl.; University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands. o.t.heidenreich@prinsesmaximacentrum.nl.; Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK. o.t.heidenreich@prinsesmaximacentrum.nl.
Publikováno v:
Leukemia [Leukemia] 2024 Nov; Vol. 38 (11), pp. 2332-2343. Date of Electronic Publication: 2024 Aug 26.
Single-cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes.
Autor:
de Kanter JK; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Steemers AS; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Gonzalez DM; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., van Ineveld RL; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Blijleven C; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Present address: University of Copenhagen Copenhagen Denmark., Groenen N; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Trabut L; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Westera L; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Beishuizen A; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Holstege FCP; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Brandsma AM; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Present address: Sanquin Blood Bank Amsterdam the Netherlands., Margaritis T; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., van Boxtel R; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Meyer-Wentrup F; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.
Publikováno v:
HemaSphere [Hemasphere] 2024 Sep 02; Vol. 8 (9), pp. e149. Date of Electronic Publication: 2024 Sep 02 (Print Publication: 2024).
Autor:
Hendriks D; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, Utrecht, The Netherlands. d.hendriks@hubrecht.eu.; Oncode Institute, Utrecht, The Netherlands. d.hendriks@hubrecht.eu.; The Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands. d.hendriks@hubrecht.eu., Artegiani B; The Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands. b.a.artegiani@prinsesmaximacentrum.nl., Margaritis T; The Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Zoutendijk I; The Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Chuva de Sousa Lopes S; Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, The Netherlands., Clevers H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, Utrecht, The Netherlands. h.clevers@hubrecht.eu.; Oncode Institute, Utrecht, The Netherlands. h.clevers@hubrecht.eu.; The Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands. h.clevers@hubrecht.eu.; University Medical Center Utrecht, Utrecht, The Netherlands. h.clevers@hubrecht.eu.; Pharma Research and Early Development (pRED) of F. Hoffmann-La Roche Ltd, Basel, Switzerland. h.clevers@hubrecht.eu.
Publikováno v:
Nature communications [Nat Commun] 2024 May 13; Vol. 15 (1), pp. 4034. Date of Electronic Publication: 2024 May 13.
Autor:
Wienke J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: j.wienke-4@prinsesmaximacentrum.nl., Visser LL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kholosy WM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Keller KM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Barisa M; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Poon E; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Munnings-Tomes S; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Himsworth C; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Calton E; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Rodriguez A; Hoffman-La Roche, Basel, Switzerland., Bernardi R; Genentech, A Member of the Roche Group, South San Francisco, CA, USA., van den Ham F; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Hooff SR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Matser YAH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Tas ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Langenberg KPS; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Lijnzaad P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Borst AL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Zappa E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bergsma FJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Strijker JGM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Verhoeven BM; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Mei S; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA., Kramdi A; Institut Curie, Inserm U830, PSL Research University, Diversity and Plasticity of Childhood Tumors Lab, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France., Restuadi R; Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK; NIHR Biomedical Research Centre, Great Ormond Street Hospital, London, UK., Sanchez-Bernabeu A; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Netherlands Proteomics Centre, Utrecht University, Utrecht, the Netherlands., Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Holstege FCP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Gray JC; Centre for Cancer Immunology, University of Southampton, Southampton, UK., Tytgat GAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Dierselhuis MP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Straathof K; University College London (UCL) Great Ormond Street Institute of Child Health, London, UK; UCL Cancer Institute, London, UK., Behjati S; Wellcome Sanger Institute, Hinxton, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Department of Paediatrics, University of Cambridge, Cambridge, UK., Wu W; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Netherlands Proteomics Centre, Utrecht University, Utrecht, the Netherlands; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore; Department of Pharmacy, National University of Singapore, Singapore, Singapore., Heck AJR; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Netherlands Proteomics Centre, Utrecht University, Utrecht, the Netherlands., Koster J; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, the Netherlands., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Janoueix-Lerosey I; Institut Curie, Inserm U830, PSL Research University, Diversity and Plasticity of Childhood Tumors Lab, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Baryawno N; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Chesler L; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Anderson J; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK; Department of Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, England, UK., Caron HN; Hoffman-La Roche, Basel, Switzerland., Margaritis T; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Noesel MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Division Imaging & Cancer, University Medical Center Utrecht, Utrecht, the Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Publikováno v:
Cancer cell [Cancer Cell] 2024 Feb 12; Vol. 42 (2), pp. 283-300.e8. Date of Electronic Publication: 2024 Jan 04.
Autor:
Hendriks D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands. Electronic address: d.hendriks@hubrecht.eu., Pagliaro A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Andreatta F; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Ma Z; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), Immunos, Singapore 138648, Singapore; Department of Pharmacy, National University of Singapore, Singapore 117543, Singapore., van Giessen J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Massalini S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., López-Iglesias C; The Maastricht Multimodal Molecular Imaging Institute, Maastricht University, Maastricht, the Netherlands., van Son GJF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands., DeMartino J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Damen JMA; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Zoutendijk I; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Staliarova N; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Bredenoord AL; Erasmus School of Philosophy, Erasmus University Rotterdam, Rotterdam, the Netherlands., Holstege FCP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Center for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands., Peters PJ; The Maastricht Multimodal Molecular Imaging Institute, Maastricht University, Maastricht, the Netherlands., Margaritis T; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Chuva de Sousa Lopes S; Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, the Netherlands., Wu W; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), Immunos, Singapore 138648, Singapore; Department of Pharmacy, National University of Singapore, Singapore 117543, Singapore., Clevers H; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands. Electronic address: h.clevers@hubrecht.eu., Artegiani B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: b.a.artegiani@prinsesmaximacentrum.nl.
Publikováno v:
Cell [Cell] 2024 Feb 01; Vol. 187 (3), pp. 712-732.e38. Date of Electronic Publication: 2024 Jan 08.
Autor:
Lin L; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands.; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., DeMartino J; Oncode Institute, Utrecht, Netherlands.; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Wang D; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., van Son GJF; Oncode Institute, Utrecht, Netherlands.; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., van der Linden R; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Begthel H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Korving J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Andersson-Rolf A; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., van den Brink S; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Lopez-Iglesias C; The Maastricht Multimodal Molecular Imaging Institute, Maastricht University, Maastricht, Netherlands., van de Wetering WJ; The Maastricht Multimodal Molecular Imaging Institute, Maastricht University, Maastricht, Netherlands., Balwierz A; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Margaritis T; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., van de Wetering M; Oncode Institute, Utrecht, Netherlands.; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Peters PJ; The Maastricht Multimodal Molecular Imaging Institute, Maastricht University, Maastricht, Netherlands., Drost J; Oncode Institute, Utrecht, Netherlands.; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., van Es JH; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Clevers H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands.; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
Publikováno v:
Science (New York, N.Y.) [Science] 2023 Oct 27; Vol. 382 (6669), pp. 451-458. Date of Electronic Publication: 2023 Oct 26.
Autor:
Visser LL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bleijs M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Margaritis T; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van de Wetering M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Holstege FCP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Molecular Medicine, UMC Utrecht and Utrecht University, Utrecht, the Netherlands., Clevers H; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre, Utrecht, the Netherlands.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2023 Oct 24; Vol. 3 (10), pp. 2158-2169.
Autor:
DeMartino J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Meister MT; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Visser LL; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Brok M; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Groot Koerkamp MJA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Wezenaar AKL; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Hiemcke-Jiwa LS; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., de Souza T; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Merks JHM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Holstege FCP; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Center for Molecular Medicine, UMC Utrecht and Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, the Netherlands., Margaritis T; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. A.Margaritis-2@prinsesmaximacentrum.nl., Drost J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. J.Drost@prinsesmaximacentrum.nl.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. J.Drost@prinsesmaximacentrum.nl.
Publikováno v:
Nature communications [Nat Commun] 2023 May 27; Vol. 14 (1), pp. 3074. Date of Electronic Publication: 2023 May 27.
Autor:
Hanemaaijer, ES, Margaritis, T, Sanders, K, Bos, FL, Candelli, T, Al-Saati, H, van, Noesel MM, Meyer-Wentrup, FAG, van, de Wetering M, Holstege, FCP, Clevers, H, Interne geneeskunde GD, dCSCA AVR, dCSCA RMSC-2, Faculteit Diergeneeskunde, CS_Cancer
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 118(5). National Academy of Sciences
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences of the United States of America, 118(5). National Academy of Sciences
Proceedings of the National Academy of Sciences
Significance Neuroblastoma is a childhood malignancy that originates from neural crest cells. We present a single-cell transcriptome and localization atlas of the developing adrenal gland and identify seven different cell clusters that make up the ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c3a84e7c4fb288538e4594a29283370
https://pubmed.ncbi.nlm.nih.gov/33500353
https://pubmed.ncbi.nlm.nih.gov/33500353